Accéder au contenu
MilliporeSigma

Passer à

TC-50L-BK

Millipore

Blood typing Bulk Reagent Diluents - ABO & RHD (Rh) Specificities

ABO Reagent Diluent

Synonyme(s) :

ABO Reagent Diluent

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

About This Item

Code UNSPSC :
41116102
Nomenclature NACRES :
NA.47

Note: For further information on price, availability or to place an order, please contact us

Forme d'anticorps

unpurified

Niveau de qualité

Forme

liquid

Conditionnement

pack of 50 L

Concentration

8-12 mg/mL protein (Total Protein Range)

Technique(s)

agglutination assay: suitable

pH

7.1-7.3

Conditions d'expédition

ambient

Température de stockage

2-8°C

Catégories apparentées

Comparer avec des articles similaires

Voir la comparaison complète

Montrer les différences

1 of 4

Cet article
364622456292364630
Anthracene-d10 98 atom % D

176591

Anthracene-d10

p-Terphenyl-d14 98 atom % D, 98% (CP)

364630

p-Terphenyl-d14

isotopic purity

98 atom % D

isotopic purity

98 atom % D

isotopic purity

98 atom % D

isotopic purity

98 atom % D

mass shift

M+10

mass shift

M+10

mass shift

M+10

mass shift

M+14

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

solid

form

solid

form

solid

form

solid

mp

210-215 °C (lit.)

mp

98-100 °C (lit.)

mp

110-113 °C (lit.)

mp

212-213 °C (lit.)

bp

340 °C (lit.)

bp

340 °C (lit.)

bp

384 °C (lit.)

bp

-

Description générale

Contains 0.1% (w/v) Sodium Azide

Filtered through a 0.22μm terminal filter

Shelf Life: 36 months from date of filtration

Product formulation examined according to Annex IV of the EU IVD directive to support CE registration.

For In Vitro use only

Application

Bulk.
For dilution of ABO reagents.

Informations légales

Millipore is a registered trademark of Merck KGaA, Darmstadt, Germany

Code de la classe de stockage

12 - Non Combustible Liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Katharina Neudorfer et al.
Diagnostic microbiology and infectious disease, 90(1), 58-63 (2017-12-03)
We tested the in vitro activity of dalbavancin, vancomycin and daptomycin against 83 enterococcal isolates in planktonic and biofilm states. The MIC90 for vancomycin-susceptible Enterococcus faecalis was 0.125 and 4μg/mL for dalbavancin and daptomycin, respectively. For vancomycin-resistant Enterococcus faecium, the
Helio S Sader et al.
Antimicrobial agents and chemotherapy, 62(3) (2017-12-22)
Dalbavancin activity was assessed against a large collection of Staphylococcus aureus isolates (n = 59,903), including isolates with decreased susceptibility to vancomycin (MIC, ≥2 mg/liter; n = 1,141), daptomycin (MIC, ≥2 mg/liter; n = 48), telavancin (MIC, ≥0.12 mg/liter; n
Zongru Guo
Acta pharmaceutica Sinica. B, 7(2), 119-136 (2017-03-18)
Drug innovation is characterized by painstaking molecular-level syntheses and modifications as the basic components of research and development. Similarly, natural products are chemically tailored and modified based upon their structural and biological properties. To some extent, the modification of natural
Michael A Pfaller et al.
International journal of antimicrobial agents, 51(4), 608-611 (2017-12-27)
Osteomyelitis is a difficult-to-treat infection that regularly involves prolonged use of systemic antibiotics. Dalbavancin has demonstrated activity against Gram-positive isolates, and has been considered as a candidate for the treatment of osteomyelitis in adults and children. This study evaluated the
Valentin Al Jalali et al.
Clinical pharmacokinetics, 57(7), 797-816 (2018-01-15)
Telavancin was discovered by modifying the chemical structure of vancomycin and belongs to the group of lipoglycopeptides. It employs its antimicrobial potential through two distinct mechanisms of action: inhibition of bacterial cell wall synthesis and induction of bacterial membrane depolarization

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique